Calcium signals determine, for example, smooth muscle contraction and changes in gene expression. How calcium signals select for these processes is enigmatic. We build on the "panjunctional sarcoplasmic reticulum" hypothesis, describing our view that different calcium pumps and release channels, with different kinetics and affinities for calcium, are strategically positioned within nanojunctions of the SR and help demarcate their respective cytoplasmic nanodomains. SERCA2b and RyR1 are preferentially targeted to the sarcoplasmic reticulum (SR) proximal to the plasma membrane (PM), i.e., to the superficial buffer barrier formed by PM-SR nanojunctions, and support vasodilation. In marked contrast, SERCA2a may be entirely restricted to the deep, perinuclear SR and may supply calcium to this sub-compartment in support of vasoconstriction. RyR3 is also preferentially targeted to the perinuclear SR, where its clusters associate with lysosome-SR nanojunctions. The distribution of RyR2 is more widespread and extends from this region to the wider cell. Therefore, perinuclear RyR3s most likely support the initiation of global calcium waves at L-SR junctions, which subsequently propagate by calcium-induced calcium release via RyR2 in order to elicit contraction. Data also suggest that unique SERCA and RyR are preferentially targeted to invaginations of the nuclear membrane. Site-and function-specific calcium signals may thus arise to modulate stimulus-response coupling and transcriptional cascades. 
INTRODUCTION

Ca
2+ signals govern a wide variety of cell functions, from muscle contraction, exocytosis and cell division to gene expression. Cells must therefore provide for the generation of different Ca 2+ signals that select for one or a combination of functions. Given the multiplicity of functional signals we must therefore ask: how can fluctuations in the concentration of one ion, Ca 2+ , exert such selective and multifaceted control? The generally accepted view is that both the spatial and temporal characteristics of Ca 2+ transients code for selective modulation of molecular targets and thereby engage appropriate cell and system function.
In all cell types stimulus-response coupling is largely controlled by interactions between voltage-gated Ca 2+ channels of the plasma membrane (PM) or its invaginations (T-tubules or caveolae) and Ca 2+ release channels in the sarco/endoplasmic reticulum (S/ER). Pharmaco-response coupling provides for greater signal diversity, via gating of the 3 known S/ER resident IP 3 receptors (IP 3 R1-3) by inositol 1,4,5 trisphosphate (IP 3 ) (Berridge, 2008) , modulation of the 3 S/ER resident ryanodine receptors subtypes (RyR1-3) by Ca 2+ and/or cyclic adenosine diphosphateribose (cADPR) (Evans et al., 2005b; Lee, 2004; Morgan and Galione, 2008) , and by the gating of the endolysosome targeted two pore channels (TPC1-3). Clearly, therefore, the spatiotemporal pattern of Ca 2+ signals will be governed by those Ca 2+ mobilising messenger(s) recruited by a given stimulus, the Ca 2+ release channels expressed by a given cell and the consequential selection by these messengers of Ca 2+ release from designate intracellular Ca 2+ stores (Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004) . However, while there is a degree of flexibility within the identified signalling pathways described thus far, the current model still appears to be too simplistic to allow for the appropriate governance of all known Ca 2+ -dependent processes from, for example, gene expression, autophagy and cell proliferation to contraction and programmed cell death.
The present article will focus on the growing body of evidence in support of the view that the functional specification of Ca 2+ signals is determined by the targeting of Ca 2+ release channels and transporters to junctional complexes formed by membrane-membrane pairs that are less than 30nm apart in all relevant cases reported to date. The specified distance of separation alone designates these complexes as nanojunctions (NOT MICRODOMAINS!) which have now been shown to exist between the S/ER and the plasma membrane (PM), lysosomes, mitochondria and the nucleus (van Breemen et al., 2013) . The underlying mechanisms of signal generation are likely more elaborate in nature and clearly rely on the strategic spatial positioning within each nanojunction of different types of Ca 2+ transporters and release channels, each of which may be characterized by different kinetics and affinities for Ca 2+ (Clark et al., 2010) .
WHAT ARE NANOJUNCTIONS?
Perhaps the first nanojunction ever described in terms of its functional importance was an intercellular junction, namely the neuromuscular junction. Here the pre-and postjunctional membranes are approximately 20 nm apart and extend roughly parallel to each other for several hundred nm. There is no doubt as to the importance of this nanojunction to our understanding of how the release of acetylcholine coordinates neuromuscular transmission (Del Castillo and Katz, 1956) . By comparison, however, little attention has been given to the presence, function and plasticity of nanojunctions between intracellular membranes. Perhaps the one exception is in skeletal and cardiac muscles, where the importance to excitation-contraction coupling of the junctional complexes formed between the T-tubules of the sarcolemma and terminal cisternae of the sarcoplasmic reticulum is well documented. Importantly, in each instance the junctional membrane pair are separated by ~20 nm or less (FranziniArmstrong, 1964; Ramesh et al., 1998; Rosenbluth, 1962) , akin to the neuromuscular junction. In cardiac muscle, sarcolemma-SR nanojunctions are essential to the targeting of Ca 2+ influx to those RyRs located on the terminal cisternae of the SR and thus to the coordination of contraction by Ca 2+ -induced Ca 2+ release from the SR. We can therefore define these sarcolemma-SR junctions as the archetypal intracellular nanojunctions that are designed to accurately deliver Ca 2+ to a defined target, RyR2, above all else. Although junctional complexes are formed between other organelles, we will concentrate on how the main Ca 2+ regulatory organelle, the sarco/endoplasmic reticulum (S/ER), generates highly localized Ca 2+ signals to select for different functions. It is now our view that all active nanojunctions constitute two biological membranes that are separated by a highly structured cytoplasmic space 10 to 50 nm in width, typically a few 100 nm in extension and that, at each side, the membrane pair contain complementary ion transporters and channels for delivery and/or receipt of specified Ca 2+ signals. As described previously, we predict that both the ultra-structure and electrostatic properties of the nanojunction together with the composition of transport molecules embedded in their limiting membranes ensure that cytoplasmic cation concentrations, Ca 2+ in particular, are locally determined. Ca 2+ may thus target "receptive sites" of different affinities and modulate function appropriately. Furthermore, we envisage that intracellular nanojunctions of the S/ER are widespread across all cell types and that they underpin the selective regulation of functions as diverse as muscle contraction, gene expression and cell division (van Breemen et al., 2013) .
THE PANJUNCTIONAL SARCOPLASMIC RETICULUM HYPOTHESIS
The first convincing evidence of nanojunctions within smooth muscle came from electron micrographs that revealed narrow gaps of ~20 nm between the peripheral or superficial SR and the PM (Devine et al., 1972; Gabella, 1971) . Once more, it is notable that the distance separating the junctional membrane pair is of the order of 20 nm. That these junctions were of functional importance was demonstrated by van Breemen, who showed that peripheral cytoplasmic domains between the PM and peripheral SR are characterized by restricted diffusion (Van Breemen, 1977) . In brief, it was concluded that once Ca 2+ enters this nanospace, it is either pumped into the SR or diffuses into the bulk myoplasm. Surprisingly, the concept that site-and function-specific Ca 2+ signals may be supported by nanojunctions received little attention thereafter, despite the general acceptance of the importance to neurotransmitter function of the neuromuscular junction and other "synapses". Perhaps this is because conceptually there is little need for considerations on junctional signalling beyond a passing nod in the direction of membrane "contact sites", "microdomains" and vague considerations on the passive transfer of ions between organelles, and, let's face it, a lack of understanding of what defining, quantifiable characteristics a true nanojunction confers. A model was therefore proposed which describes the evidence in support of a "Pan-Junctional SR" which incorporates identified nanojunctions between the SR and the PM, mitochondria, lysosomes and the nucleus, each performing separate, but coordinated functions (van Breemen et al., 2013) . The most abundant PM-SR junctions appear to selectively regulate luminal [Ca 2+ ] SR , hyperpolarization and relaxation, depolarization and vasomotion. These aside, mitochondria-SR junctions regulate mitochondrial energy metabolism, lipid transport, apoptosis and SR Ca 2+ loading (Rowland and Voeltz, 2012) and lysosome-SR junctions underpin evoked calcium-induced calcium release (CICR) from the S/ER which may in turn modulate, for example, contraction, autophagy and cholesterol metabolism (Fameli et al., 2014; Zhu et al., 2010) .
Due to the fact that their size alone renders nanojunctions beyond the resolution of current live cell experimentation, their importance to the coordination of ion exchange was first truly visualised by 3-D models of Ca 2+ flux across the PM-SR junction of smooth muscles. These models incorporated dimensionally realistic intracellular architecture, transporter kinetics and density, and outcomes suggested that increases of one single Ca 2+ ion may raise the local concentration from nanomolar to micromolar; i.e., considerations on bulk concentration may become irrelevant. Despite the fact that these models only accounted for the stochastic element of diffusion, they also highlighted that the functional integrity of PM-SR junctions relies heavily on the close apposition of the two membranes, since various interrogations of these models demonstrated that a separation of less than 50 nm adequately provided for compartmentalised Ca 2+ signalling, and that junctional integrity was lost when the separation of PM and the junctional SR was raised above 50 nm (Fameli et al., 2007) . These studies apart, it could be argued that there is perhaps a lack of additional defining and quantifiable characteristics to extrapolate this argument across the cell. However, we would counter this position by stating that our studies on pulmonary arterial smooth muscle have provided quantitative evidence in support of a requirement for junctional signalling beyond that originally envisaged at the superficial buffer barrier created by PM-SR nanojunctions. In order to develop this hypothesis further, we will therefore focus on the putative cellular nanojunctions of pulmonary arterial myocytes, with reference to other cell types for comparison.
PULMONARY ARTERY DILATION MAY BE MEDIATED BY CADPR-DEPENDENT ACTIVATION OF RYANODINE RECEPTORS
Our journey towards a realisation of the importance of nanojunctions began with the simple assessment of changes in cytoplasmic Ca 2+ concentration upon intracellular dialysis of cADPR from a patch-pipette. High concentrations of cADPR (100 mol L 1 ) induced global increases in intracellular Ca 2+ concentration (Evans, unpublished) . However, relatively low concentrations (20 mol L 1 ) only increased cytoplasmic Ca 2+ concentration at the perimeter of the cell and elicited a concomitant membrane hyperpolarisation (Boittin et al., 2003) . The hyperpolarisation was reversed by the highly selective BK Ca channel antagonist iberiotoxin, by chelating intracellular Ca 2+ with BAPTA, by selective block of RyRs with ryanodine and by "depletion" of SR stores by blocking SERCA with cyclopiazonic acid. Most importantly, hyperpolarisation by cADPR was blocked by two different cADPR antagonists. Given that cADPR synthesis had been shown to be up-regulated in a cAMP-and PKA-dependent manner in cardiac muscle (Higashida et al., 1999) , it seemed likely that cADPR could mediate hyperpolarisation by adenylyl cyclase coupled receptors, such as -adrenoceptors. Consistent with this proposal and previous studies on smooth muscle from a variety of tissues (for review see (Jaggar et al., 2000) ) we found that isoprenaline and cAMP induced hyperpolarisation in isolated pulmonary arterial myocytes, and demonstrated that in each case hyperpolarisation exhibited similar pharmacology to hyperpolarisation by cADPR (Boittin et al., 2003) . Strikingly, however, the selective PKA antagonist H89 blocked hyperpolarisation by both isoprenaline and cAMP, but was without effect on hyperpolarisation by cADPR. It would appear, therefore, that cADPR is a downstream element in this signalling cascade. Further support for this proposal was derived from studies on isolated pulmonary artery rings without endothelium; vasodilation evoked in response to -adrenoceptor activation by isoprenaline was inhibited (~50%) by blocking cADPR with the membrane permeable antagonist 8-bromo-cADPR, RyRs with ryanodine and, consistent with the hyperpolarization, by blocking SERCA pumps by pre-incubation with cyclopiazonic acid (Figure 1 ). We concluded that isoprenaline-induced vasodilation of pulmonary arteries was, in part, evoked by cADPR-dependent activation of RyRs on a cyclopiazonic acid-sensitive SR store, and the subsequent activation of BK Ca upon the mobilisation of Ca 2+ from this store (Boittin et al., 2003) . This seemed quite consistent with the view that activation of BK Ca channels resulted from the induction of highly localised (i.e. non-propagating) cADPR-dependent Ca 2+ sparks. In short, at first sight outcomes did not appear to require considerations on junctional coupling between the PM and the SR. Our position was, however, altered by observations in relation to pulmonary artery constriction in response to hypoxia.
REGULATION BY HYPOXIA OF CALCIUM MOBILISATION FROM SARCOPLASMIC RETICULUM IN PULMONARY ARTERIAL SMOOTH MUSCLE
Before we can elaborate further we must describe the mechanisms that underpin hypoxic pulmonary vasoconstriction (HPV), the defining characteristic by which pulmonary arteries contribute to ventilation-perfusion matching at the lung; systemic arteries dilate in response to hypoxia.
In isolated pulmonary arteries, HPV is biphasic when induced by switching from normoxic to hypoxic gas mixtures (Figure 2 ), an initial transient constriction (Phase 1) being followed by a slow tonic constriction (Phase 2) Robertson et al., 1995) . Both phases of constriction are superimposed upon each other, i.e., they are discrete events that are initiated immediately upon exposure to hypoxia. The initial transient constriction peaks within 5-10 min of the hypoxic challenge, whilst the underlying, tonic constriction peaks after 30-40 min. When the endothelium is removed the gradual amplification of Phase 2, which is driven by the release of an endothelium-derived vasoconstrictor, is not observed and the Phase 1 constriction now declines to a maintained plateau ( Figure 2 ) . Continued smooth muscle SR Ca 2+ release via RyRs is required for both the induction (Phases 1 and 2) and maintenance (Phase 2) of HPV in isolated pulmonary arteries both with and without endothelium . This is evident from the fact that: (i) HPV is abolished following block of SR Ca 2+ release via RyRs, whilst constriction in response to membrane depolarisation (80 mmol L 1 K + ) and consequent voltage-gated Ca 2+ influx remains unaffected; (ii) HPV persists after removal of extracellular Ca 2+ , despite the fact that constriction induced by depolarisation is abolished. Maintained constriction of pulmonary artery rings is, however, attenuated by up to 50% in Ca 2+ free medium (Evans et al., 2005a) , consistent with the view that HPV is supported by consequent activation of storedepletion activated Ca 2+ entry (Weigand et al., 2005) . Clearly, therefore, HPV within an intact artery is triggered by the mobilization during hypoxia of SR Ca 2+ stores via RyRs and in manner determined by mechanisms intrinsic to pulmonary arterial myocytes. However experimental out- Figure 2 Hypoxic pulmonary vasoconstriction is mediated by intracellular calcium release in pulmonary arterial smooth muscles. A(i), record indicating Phase 1 and Phase 2 of the response of an intact pulmonary artery ring to hypoxia, with the three identified components of HPV: cADPR-independent SR calcium release (black) cADPR-dependent SR calcium release (grey) and endothelium-dependent constriction (white). A(ii), constriction by hypoxia of a pulmonary artery ring without endothelium. B(i), constriction by hypoxia of an intact pulmonary artery ring in the absence of extracellular calcium. B(ii), constriction by hypoxia of a pulmonary artery ring without endothelium in the absence of extracellular calcium.
comes revealed a picture that was yet more complex.
The first truly unexpected observation was that cyclopiazonic acid blocked the Phase 1 constriction but had no effect on Phase 2 (Figure 3 ) , despite the fact that both phases of HPV were entirely dependent on the mobilisation of Ca 2+ from the SR. This presented us with a further paradox, however, given that our data already suggested that SR Ca 2+ release via RyRs underpinned vasodilation consequent to -adrenoceptor activation and also underpinned both phases of HPV ). More curious still, the effect on HPV of pre-incubating arteries with cyclopiazonic acid was precisely the reverse of outcomes following pre-incubation of arteries with 8-bromo-cADPR, which abolished Phase 2 of HPV without affecting Phase 1 (Figure 2 ) . At the time we concluded that Phase 1 might be mediated by the mobilization of an SR compartment served by a cyclopiazonic acid-sensitive SERCA that is inhibited by hypoxia due to a fall in ATP supply, i.e., a reduction in sequestration by this pump might facilitate evoked SR Ca 2+ release. To allow for this and a second phase of constriction driven by maintained cADPR-dependent SR Ca 2+ release, we suggested that one would require the presence of a second, spatially segregated SR Ca 2+ store that is served by a different, cyclopiazonic acid-insensitive SERCA pump Evans et al., 2005b) .
Although these findings provided our first evidence of functionally segregated SR stores and allowed for further interrogation of our anomalous findings, they presented us with a further paradox. Our data suggested that cADPRdependent SR Ca 2+ release via RyRs mediates both vasodilation and vasoconstriction of pulmonary arteries, and in a stimulus-specific manner. We concluded that this could only be explained if -adrenoceptor signalling targets PKA-dependent cADPR synthesis to RyRs of the "peripheral" SR that is in close apposition to BK Ca channels in the plasma membrane (i.e., to PM-SR junctions), whilst cADPR-dependent vasoconstriction results from the activation of a discrete subpopulation of RyRs localized in the "central" SR. Clearly, our data suggested that these discrete SR compartments would have to be served by different SERCA pumps. More precisely, evidence pointed to the possibility that one peripheral SR compartment in close apposition to the plasma membrane would be served by a SERCA pump that is sensitive to cyclopiazonic acid and, by contrast, a second, central SR compartment might be in close apposition to the contractile apparatus and be served by a SERCA pump that is insensitive to cyclopiazonic acid (Boittin et al., 2003; Evans et al., 2005b ). This conclusion gained further support from our finding that both SR Ca 2+ release in response to hypoxia Salvaterra and Goldman, 1993) and HPV are abolished following SR store depletion by block of SERCA with thapsigargin (Evans, unpublished). In complete agreement with our proposal, previous studies on smooth muscle, the pulmonary vasculature included, have provided evidence of discrete SR compartments (Ethier et al., 2001; Golovina and Blaustein, 1997; Iino et al., 1988; Janiak et al., 2001; Tribe et al., 1994; Yamaguchi et al., 1995) . Most significantly, some of these studies shared one common piece of evidence, that the SERCA pump antagonist cyclopiazonic acid selectively depleted one of at least two functionally segregated SR compartments. We therefore sought to determine whether or not multiple SERCA were expressed in pulmonary arterial smooth muscle and, if so, their respective spatial distribution.
SERCA2A AND SERCA2B SERVE DISCRETE SR COMPARTMENTS IN PULMONARY ARTERIAL SMOOTH MUSCLE
In agreement with previous studies on vascular smooth muscle (Eggermont et al., 1990) , we found that SERCA2a and SERCA2b are functionally expressed in pulmonary arterial smooth muscle. Most importantly we identified striking differences in the spatial organization of each of these pumps by visual and semi-quantitative analysis; the distribution by density of labelling for each SERCA isoform within the subplasmalemmal (within 1 m of the plasma membrane) the perinuclear (within 1.5 m of the nucleus) and the extraperinuclear (remainder of the cell) volumes (Clark et al., 2010) . The vast majority of SERCA2b labelling, ~70%, lay within the subplasmalemmal region, with only ~8% and ~20% of labelling present in the extraperinuclear and perinuclear regions, respectively ( Figure 4 ). In marked contrast, SERCA2a labelling was almost entirely (~90%) restricted to the perinuclear region of pulmonary arterial smooth muscle cells (Figure 4 ). These data suggest, therefore, that native SERCA2b may be sensitive to cyclopiazonic acid and supply an SR compartment that sits proximal to the plasma membrane and underpins Ca 2+ -dependent vasodilation via adenylyl cyclase coupled receptors, while SERCA2a may supply the putative central SR compartment and represent a cyclopiazonic acidinsensitive, thapsigargin-sensitive SERCA that underpins pulmonary artery constriction by hypoxia.
In this respect it was intriguing to note that SERCA2a and SERCA2b exhibit distinct kinetics. SERCA2b, which may serve PM-SR junctions, has a higher affinity for Ca 2+ but lower V max than the more centrally located SERCA2a (Verboomen et al., 1992) . SERCA2b may therefore be dominant under quiescent conditions and function to maintain low levels of cytoplasmic Ca 2+ in the vicinity of the ATPase; importantly this has a physiological precedent in that it mirrors the relationship between uptake 1 and uptake 2 at noradrenergic synapses, the relative affinity and V max of which determines the concentration-dependent selection of pre-and post-junctional catecholamine uptake by these transporters. These findings began to square the circle when taken together with our observation that RyR1 is primarily targeted to the subplasmalemmal region of the pulmonary arterial myocytes (Kinnear et al., 2008) , because considerations on the kinetics of RyR1 regulation by Ca 2+ were equally revealing. RyR1 exhibits relatively little gain in Po (0-0.2) with increasing cytoplasmic Ca 2+ concentration, and inactivates within the mol L 1 range with full inactivation achieved by 1 mmol L 1 cytoplasmic Ca 2+ ; this may, in part, explain the low gain in Po for RyR1 in response to activation by Ca 2+ . Due to these facts RyR1 likely provides limited support for signal propagation by CICR (Yang et al., 2001) . When allied to the high affinity of SERCA2b for Ca 2+ and their respective targeting to PM-SR junctions, the properties of pump and release channel may therefore aid the functional segregation of PM-SR junctions from the bulk cytoplasm. Furthermore it is now apparent that of the available RyRs, RyR1 is most sensitive to activation by cADPR (Ogunbayo et al., 2011) ; as investigations on vasodilation consequent to -adrenoceptor activation had predicted the RyR resident within PM-SR junctions might be.
ARE PM-SR JUNCTIONS POLYMODAL?
It is possible that PM-SR junction may, given the above, be polymodal. This is clear from the fact that the SR retains the capacity to not only empty when overloaded with Ca 2+ (Nazer and van Breemen, 1998a) or signaled to do so by vasodilators (Boittin et al., 2003) but to reload its Ca 2+ store once depleted. In short, in order to support continued Ca 2+ release into the cytoplasm, the S/ER must be replenished by Ca 2+ influx from the extracellular fluid, i.e., via storedepletion activated Ca 2+ entry pathways (Ginsborg et al., 1980a, b; Putney, 1986 ). Although we have not studied the mechanisms involved in any detail, our findings are entirely consistent with the view that HPV is supported, but not initiated or maintained, by such store-depletion-activated calcium entry in pulmonary arterial myocytes Evans et al., 2005a) .
Refilling of the SR of smooth muscles is accomplished, in part, via PM-SR junctions, which facilitate Ca 2+ flux from the extracellular space into the SR via SERCA during activating waves of SR Ca 2+ release (Lee et al., 2001) . As in all cell types, a variety of mechanisms support SR refilling during stimulated Ca 2+ release. Receptor-operated cation channels, such as the transient receptor potential channel TRPC6, may deliver Na + to the junctional nanospace in a manner that initiates Ca 2+ entry via reverse mode Na + /Ca 2+ exchangers (NCX) in the PM, and thus supply Ca 2+ to SERCA on the adjacent, junctional SR membranes (Fameli et al., 2007 (Fameli et al., , 2009 Poburko et al., 2007) . SR reloading via SERCA may also be facilitated by Ca 2+ influx through VGCCs (Takeda et al., 2011 ), TRPCs (Albert et al., 2009 Rosado et al., 2015; Shi et al., 2016) , and the stromal interaction molecule (STIM)/Orai system (Berra-Romani et al., 2008; Soboloff et al., 2012; Takahashi et al., 2007) .
All of these mechanisms appear to contribute to SR loading in pulmonary arterial myocytes (Leblanc et al., 2015; Lu et al., 2008; Ogawa et al., 2012) , although it should be noted that evidence suggests that discrete pathways of receptor-operated Ca 2+ influx may be modulated by IP 3 (Kato et al., 2013; Snetkov et al., 2006) . That aside, the activation of both TRPCs (Weissmann et al., 2006) and STIM/Orai complexes (Lu et al., 2009; Ng et al., 2012) likely contributes to store-operated Ca 2+ entry during HPV.
HPV IS DETERMINED BY SR JUNCTIONAL COUPLING AT AN "INTRACELLULAR SYNAPSE"
As mentioned previously the effects of a cADPR antagonist, 8-bromo-cADPR, on HPV in isolated pulmonary artery rings were quite different from the effects of ryanodine and caffeine. In arteries with and without endothelium, 8-bromo-cADPR had no effect on Phase 1 of HPV. However, it abolished Phase 2 in the presence of the endothelium and blocked the maintained constriction observed in arteries without endothelium (Figure 3 ) . Therefore, while cADPR-dependent SR Ca 2+ release is required for the initiation and maintenance of Phase 2 of acute HPV in isolated pulmonary artery rings, cADPR is not required to support the majority of SR Ca 2+ release during the Phase 1 constriction.
Surprisingly, however, and against our expectation at the time, when arteries were pre-incubated with the cADPR antagonist 8-bromo-cADPR, Phase 2 of HPV was blocked in an all-or-none manner . Briefly, following pre-incubation of isolated pulmonary arteries with 1 mol L 1 8-bromo-cADPR HPV remained unaltered ( Figure 5 ), but pre-incubation with 3 mol L 1 8-bromo- Figure 5 8-bromo-cADPR blocks HPV in an all-or-none manner. Upper panels show that pre-incubating intact pulmonary arteries with 8-bromo-cylic ADP-ribose, a cADPR antagonist, at (i) 1 mol L 1 has no effect but produces all-or-none block of Phase 2 at (ii) 3 mol L 1 . By contrast, lower panel shows concentration-dependent reversal of maintained HPV by 8-bromo-cylic ADP-ribose in an artery without endothelium.
cADPR abolished the maintained constriction observed during Phase 2. This outcome is incompatible with the block by a competitive antagonist, such as 8-bromocADPR, of a simple process of "agonist-receptor" coupling.
The aforementioned observations were all the more curious given that once initiated the maintained phase of constriction (in pulmonary arteries without endothelium) was reversed by 8-bromo-cADPR in a concentration-dependent manner and with complete block requiring a concentration of 100 mol L 1 ), approaching 2 orders of magnitude higher than required for all-or-none block following pre-incubation with 8-bromocADPR ( Figure 5 ). Such concentration-dependent reversal of maintained HPV is entirely consistent with the inhibition by a competitive antagonist of "agonist-receptor" coupling at a single population of receptors, quite unlike the all-or-none block observed following pre-incubation with 8-bromo-cADPR. These findings are reminiscent of the block by -bungarotoxin (or tubocurarine) of transmission at the neuromuscular junction, where inhibition of more than 45% of skeletal muscle nicotinic acetylcholine receptors blocks neuromuscular transmission in an all-or-none manner (Katz, 1967; Lee et al., 1977) . By contrast, following induction of tetanus -bungarotoxin, for example, is less effective and reverses muscle contraction in a concentration-dependent manner (Lee et al., 1977) . We concluded that a similar "margin of safety" may also be built into HPV, and suggested that the cADPR-dependent component of HPV may be initiated in an all-or-none manner. In essence, we were considering the possible existence of "junctional RyRs" that could confer all-or-none block of HPV upon pre-incubation with 8-bromo-cADPR, by blocking "activation by cADPR of a certain proportion of RyRs", or by "cADPR-dependent Ca 2+ mobilisation from a subpopulation of RyRs" that are pivotal to the initiation of maintained HPV Evans et al., 2005b) . All things considered, our view was that HPV was, in part, determined by the initiation of a Ca 2+ signal within an intracellular junction of the SR.
This proposal offers greater complexity than one might imagine, given that RyR subtypes 1, 2 and 3 are highly co-expressed in smooth muscles (Herrmann-Frank et al., 1991; Neylon et al., 1995) . Not least because all three RyR subtypes can be expressed in a cADPR-sensitive form and each may exhibit different sensitivities to both Ca 2+ and cADPR. In short, the RyR subtype targeted by a given Ca 2+ signal could affect markedly the characteristics of any subsequent amplification process.
NAADP INDUCES GLOBAL Ca 2+ WAVES AND SMOOTH MUSCLE CONTRACTION VIA LYSOSOME-SR JUNCTIONS
The junctional complex via which HPV is initiated may have been revealed during subsequent studies on Ca 2+ mobilization by nicotinic acid adenine dinucleotide phosphate (NAADP). Importantly, these studies suggested that NAADP initiates global Ca 2+ waves in an all-or-none manner in pulmonary arterial myocytes, and does so via a two-pool system (Boittin et al., 2002) (Boittin et al., 2002) . We subsequently provided evidence, in a variety of cell types, that NAADP-dependent Ca 2+ signals are supported by endolysosome targeted TPCs (TPCN1-3, gene name) (Brailoiu et al., 2009 (Brailoiu et al., , 2010 Cai and Patel, 2010; Calcraft et al., 2009; Ruas et al., 2010; Zhu et al., 2010; Zong et al., 2009 ); TPC1 was first described by Ishibashi and co-workers although no functional role was identified (Ishibashi et al., 2000) . It should be noted, however, that the role of TPCs in endolysosomal Ca 2+ signalling remains controversial, on the grounds of ion selectivity and the capacity for TPC channel gating by the Ca 2+ mobilizing messenger NAADP (Jha et al., 2014; Morgan and Galione, 2014; Pitt et al., 2010; Ruas et al., 2015; Schieder et al., 2010; Wang et al., 2012) . Nevertheless, substantial evidence suggests that NAADP may trigger intracellular Ca 2+ release from acidic stores in a manner that may be supported by all three subtypes of vertebrate TPCs. Of these, only the lysosome targeted TPC2 or TPC3 confer the level of L-S/ER coupling necessary for subsequent amplification of Ca 2+ bursts from acidic stores by CICR from the S/ER (Ogunbayo et al., 2015b) , and TPCN3 is absent in primates (including humans) and some rodents (e.g. mouse, rat) (Calcraft et al., 2009 ). Our preliminary observations on pulmonary arterial myocytes are consistent with this view, in that NAADP-evoked global Ca 2+ waves are abolished in myocytes from Tpcn2 knockout mice (Ogunbayo et al., 2015a) .
In the context of the present article, however, it is perhaps most significant that depletion of SR Ca 2+ stores by inhibition of the SERCA pump with thapsigargin (not shown) or block of RyRs with ryanodine (Figure 6 ), revealed spatially restricted bursts of Ca 2+ release in response to NAADP that failed to propagate away from their point of initiation in the absence of either SR stores replete in Ca 2+ or functional RyRs (Boittin et al., 2002; Kinnear et al., 2004) . In short, NAADP initiates global Ca 2+ waves in an all-or-none manner by mobilising acidic, lysosome-related Ca 2+ stores that subsequently evoke Ca 2+ -induced Ca 2+ release (CICR) from the SR via RyRs (Kinnear et al., 2004) . NAADP-induced Ca 2+ bursts must therefore breach a given threshold in order to elicit a global Ca 2+ wave by CICR via RyRs on the SR, and in a manner reminiscent of excitation-contraction coupling at the neuromuscular junction.
Intriguingly, intracellular dialysis of IP 3 evoked regener- transients were blocked by the IP 3 R antagonist xestospongin C (Boittin et al., 2002) . This suggests that in pulmonary arterial myocytes lysosomes couple to the SR by CICR via RyRs but not IP 3 Rs, i.e., each may be targeted to different regions of the SR. Indirect support for this view has been provided by the findings of others (Janiak et al., 2001; Subedi et al., 2014) .
LYSOSOME-SARCOPLASMIC RETICULUM JUNCTIONS FORM A TRIGGER ZONE FOR CALCIUM SIGNALLING BY NAADP
Using LysoTracker Red as a fluorescent label for acidic organelles in acutely isolated pulmonary arterial myocytes, we demonstrated that lysosomes form tight perinuclear clusters in a manner consistent with the spatially restricted nature of Ca 2+ bursts triggered by NAADP. Importantly, lysosomal clusters were closely associated with a subpopulation of RyRs labelled with Bodipy-Ryanodine ( Figure 7 ) and were separated from these RyRs by a narrow junction, that was well beyond the resolution of deconvolution microscopy (0.2 m) (Kinnear et al., 2004 stores to a subpopulation of RyRs could also serve to provide the aforementioned "margin of safety" with respect to the initiation of HPV, should lysosome-related Ca 2+ release play a role, and confer all-or-none block of HPV by 8-bromo-cADPR due to consequent increases in the threshold for CICR.
We have recently characterised L-SR junctions of rat pulmonary arterial myocytes in greater detail using standard (2D) transmission electron microscopy, and found them to Figure 7 Lysosomes co-localize with ryanodine receptors to form a trigger zone for calcium signalling in response to NAADP. Left hand panel, 3-D reconstruction of a deconvolved Z-stack of images from a pulmonary artery smooth muscle cell showing co-localization (yellow) of lysosomes labelled with LysoTracker Red (red) and ryanodine receptors (RyRs) labelled with Bodipy-Ryanodine (green). Right hand panels, show (from left to right) the distribution relative to the DAPI labelled nucleus of IGP120, a lysosome-specific marker, and labelling for RyR3, RyR2 and RyR1. be a regularly occurring features of these cells. The L-SR widths of pulmonary arterial myocytes, that is the distance between lysosomal and SR membranes, were ~16 nm and had a lateral extension of ~300 nm (Fameli et al., 2014) . These L-SR junctions are therefore true nanojunctions and exhibit a junctional separation equivalent to the PM-SR junction and, once more, akin to that of the neuromuscular junction. Moreover, assessment of the 3D morphology of L-SR junctions by tomographic transmission electron microscopy showed that some SR segments actually branched out to form narrow cisternae, with a single extension of the SR capable of coupling with multiple organelles. Modeling of this junctional complex has provided strong mechanistic support for our proposals on Ca 2+ signaling within L-SR junctions. Firstly, localized [Ca 2+ ] transients due to junctional Ca 2+ release reach, without fail, values required to breach the threshold for CICR from junctional RyRs (see below). Perhaps most significantly, however, disruption of the nanojunctions decreases the maximum attainable junctional [Ca 2+ ] to values below those required for CICR via RyRs. Consistent with previous studies on the PM-SR junctions, these analyses also predicted a 30-50 nm functional operating limit for the width of L-SR junctions, above which there is loss of junctional integrity and inadequate control of ion movements within the junctional space. In short, L-SR nanojunctions as reported appear necessary and sufficient for the generation of Ca 2+ bursts and their subsequent amplification into propagating, global Ca 2+ waves (Fameli et al., 2014) .
LYSOSOMES CO-LOCALIZE WITH RYR SUBTYPE 3 TO FORM A TRIGGER ZONE FOR CALCIUM SIGNALLING BY NAADP IN PULMONARY ARTERIAL SMOOTH MUSCLE
Given that our findings suggested that a subpopulation of RyRs within a junctional complex might underpin HPV and Ca 2+ signalling via L-SR junctions, we sought to determine whether or not lysosomes selectively couple to one of the three RyR subtypes expressed in arterial smooth muscle, namely RyR1, RyR2, or RyR3 (Kinnear et al., 2008) . As before, the distribution of labelling for a given protein by density was determined for each of three defined regions of the cell relative to the nucleus (defined by DAPI labelling), namely the perinuclear, the sub-plasmalemmal and the extra-perinuclear region. The density of labelling for a specific lysosome marker (lgp120) was ~2 fold greater in the perinuclear than observed within the extra-perinuclear region and ~4-fold greater than was observed in the subplasmalemmal region of cells, with dense clusters of labelling evident in the perinuclear region compared to a more diffuse distribution of labelling outside this region. In common with the distribution of lysosomes, RyR3 labelling was concentrated within the perinuclear region of the cell where it was ~4 and ~14-fold greater than that in the extra-perinuclear and sub-plasmalemmal regions, respectively. Furthermore, the density of RyR3 labelling within the perinuclear region was ~2-fold higher than that for either RyR1 or RyR2.
The density of colocalization between lysosomes and each RyR subtype within the perinuclear region of the cell revealed that RyR3 colocalized with ~41% of the total volume of lysosome labelling, with the density of colocalization being ~4-and ~60-fold greater than that observed in the extra-perinuclear or sub-plasmalemmal regions, respectively. In marked contrast, labelling for RyR2 and RyR1 colocalized with only 13% and 14%, respectively, of the total volume of lysosome labelling within the perinuclear region and their respective density of colocalization was approximately 2-fold lower than that for RyR3. Furthermore, the mean volume of colocalization between RyR3 and lysosomes was ~2 fold greater than that for either RyR1 or RyR2. We concluded, therefore, that lysosomal clusters preferentially colocalize with RyR3 in the perinuclear region of the cell to from a trigger zone for Ca 2+ signalling at L-SR junctions.
WHY MIGHT RYR3 BE TARGETED TO LYSOSOME-SR JUNCTIONS?
A determining factor in this respect could be the relative sensitivity of each RyR subtype to CICR, the maximum gain in response to Ca 2+ and the relative sensitivity of each receptor subtype to inactivation by Ca 2+ (Chen et al., 1997; Li and Chen, 2001) . The threshold for activation of RyR1, RyR2 and RyR3 is similar, with channel activation at cytoplasmic Ca 2+ concentrations >100 nmol L 1 . However, estimates of the EC 50 are different, with half maximal activation at >250 nmol L 1 for RyR2 and >400 nmol L 1 for RyR3. The higher EC 50 exhibited by RyR3 could be significant, because this would provide for a higher "margin of safety" with respect to the all-or-none amplification of Ca 2+ bursts from lysosomal Ca 2+ stores by CICR via RyRs at the lysosome-SR junction, i.e., the probability of false events being initiated would be lower for RyR3 than for RyR2. For the provision of such a margin of safety by RyR3, but not RyR2, our simulations estimate that half maximal SR Ca 2+ release via RyR3 would need to occur at an L-SR junctional Ca 2+ concentration of ~10 μmol L 1 (Fameli et al., 2014) . Another factor that may be of significance is that whilst the mean open time versus cytoplasmic Ca 2+ concentration for RyR2 and RyR3 are comparable and increase approximately 10-fold over their activation range, the mean open time for RyR1 is much lower and increases only 2-fold over its activation range. Furthermore, comparison of the Po versus cytoplasmic Ca 2+ concentration curves shows that RyR3 (0-1) exhibits a higher gain in Po than does RyR2 (0-0.9), whilst RyR1 (0-0.2) exhibits relatively little gain in Po with increasing cytoplasmic Ca 2+ concentration (Chen et al., 1997; Li and Chen, 2001) . Therefore, once the threshold for activation is breached RyR3 would offer greater amplification of Ca 2+ bursts from lysosomal Ca 2+ stores than would RyR2, whilst amplification via RyR1 would be marginal (see also (Manunta et al., 2000; Yang et al., 2001) (Chen et al., 1997; Li and Chen, 2001) . In marked contrast, RyR1 inactivation occurs within the mol L 1 range and full inactivation is achieved by 1 mmol L 1 Ca 2+ . Its sensitivity to inactivation by Ca 2+ would therefore render RyR1 unsuitable for a role in the amplification of Ca 2+ bursts at lysosome-SR junctions because the local Ca 2+ concentration may exceed the threshold for RyR1 inactivation. Therefore, the functional properties of RyR3 make it best suited to a role in the amplification of Ca 2+ bursts at lysosome-SR junctions.
HOW MAY Ca 2+ SIGNALS PROPAGATE AWAY FROM LYSOSOME-SR JUNCTIONS TO THE WIDER CELL IF RYR3 IS TARGETED TO THE PERINUCLEAR REGION OF CELLS?
Significantly, the density of RyR3 labelling declines markedly (between 4-and 14-fold by region) outside of the perinuclear region of the cell (Kinnear et al., 2008) . It seems unlikely, therefore, that RyR3 functions to carry a propagating Ca 2+ wave far beyond the point of initiation of CICR within the proposed trigger zone for Ca 2+ signalling via L-SR junctions. Given this finding it may be of significance that the density of labelling for RyR2 increases markedly in the extra-perinuclear region when compared to the perinuclear region and exhibits a ~3-fold greater density of labelling within this region than observed for either RyR3 or RyR1. This suggests that RyR2, but not RyR1, may function to receive Ca 2+ from RyR3 at the interface of the lysosome-SR junction and thereby allow for further propagation of the Ca 2+ signal via CICR. Such a role would be supported by the lower EC 50 for CICR via RyR2, which would insure that once initiated a propagating Ca 2+ wave would be less prone to failure. Furthermore, relative to RyR1, its greater intrinsic gain and lower sensitivity to inactivation by Ca 2+ would render RyR2 most suitable to a role in the wider propagation of a global Ca 2+ wave. If clusters of RyR3 do indeed sit within the lysosome-SR junction and an array of RyR2 carries propagating Ca 2+ signals away from this junction to trigger HPV, preincubation of pulmonary arteries with 8-bromo-cADPR could block HPV in an all-or-none manner by increasing the threshold for CICR via RyR3 and/or RyR2. Furthermore, once initiated, if regenerative, propagating Ca 2+ waves via RyR2 are maintained by an increase in cADPR accumulation in the absence of further Ca 2+ release from lysosomerelated stores, 8-bromo-cADPR could reverse associated pulmonary artery constriction in a concentration-dependent manner. In this respect it is important to note that Ca 2+ may also sensitise RyRs to activation by cADPR (Panfoli et al., 1999) . The combinatorial effects of Ca 2+ and cADPR are therefore of fundamental importance (Morgan and Galione, 2008) , not least with regard to the threshold for activation of RyRs by either agent. Moreover the threshold for CICR via RyRs may also be modulated by the luminal Ca 2+ concentration of the SR (Beard et al., 2002; Ching et al., 2000; Gilchrist et al., 1992; Gyorke and Gyorke, 1998; Tripathy and Meissner, 1996) , which could in turn be primed by Ca 2+ taken up via SERCA2a during lysosomal Ca 2+ bursts that fail to breach the threshold for CICR from the SR.
At this point it may be important to note that even though the Ca 2+ signalling domain for contraction may be of a larger scale, its distribution is far from homogeneous. Separate PM regions have been described for filament attachment and caveolae (Moore et al., 2004) and the density of myosin filaments appears to be less in the cell periphery than central myoplasm (Lee et al., 2002) . In addition, the functional Ca 2+ -binding protein calmodulin is tethered to the myofilaments rather than free in solution (Wilson et al., 2002) . Therefore, we cannot rule out the capacity for SRmyofilament coupling along the path of propagating Ca 2+ waves, with a path length between the SR membrane pairs and calmodulin being on the nanoscale.
IS THERE A FUNCTIONAL REFERENCE POINT FOR THE TWO PHASES OF SR CALCIUM RELEASE DURING HYPOXIA?
Given that vasodilation in response to activation of adenylyl cyclase coupled receptors and Phase 1 of HPV are inhibited by cyclopiazonic acid, they likely utilise a common SR store. It is possible, therefore, that SR Ca 2+ release by hypoxia serves two purposes. Hypoxia may primarily trigger constriction by cADPR-dependent Ca 2+ release from a central SR compartment(s) that is in close apposition to the contractile apparatus and served by a cyclopiazonic acid-insensitive SERCA pump (SERCA2a). A secondary action of hypoxia may be to deplete a peripheral SR compartments, by inhibition of a cyclopiazonic acid-sensitive SERCA pump (SERCA2b), that are in close apposition to the plasma membrane and which normally mediate vasodilation by releasing Ca 2+ via RyR1 within PM-SR junctions in order to trigger membrane hyperpolarization and thus facilitate Ca 2+ sequestration via plasma membrane Ca
2+
ATPases and forward mode activity of Na + /Ca 2+ exchangers. This might explain why pulmonary vasodilation by -adrenoceptor activation is abolished by hypoxia (McIntyre et al., 1995) and why HPV is enhanced by cyclopiazonic acid (Morio and McMurtry, 2002) but abolished by thapsigargin (Evans unpublished) . In this respect it is also intriguing to note that in pulmonary arterial myocytes from patients with pulmonary arterial hypertension a sustained rise in cAMP increases store-operated Ca 2+ entry via a PKA-dependent pathway, but inhibits store-operated calcium entry in pulmonary arterial myocytes from normotensive patients (Zhang et al., 2007) . When considered together, these data point to a pathological swing in the balance of support for store-emptying towards store-refilling at the PM-SR junctions. Consistent with this view, it has been proposed that the progression of hypoxic and idiopathic pulmonary hypertension may be facilitated by increases in expression of TRPC1, 3, 4 and 6, and thus enhanced store-operated Ca 2+ entry (Liu et al., 2012; Yu et al., 2009; Zhang et al., 2007 Zhang et al., , 2014 . This may also support the switch from contractile to the proliferative and migratory smooth muscle phenotypes that underpins disease progression (Fernandez et al., 2015) .
BEYOND THE CONTRACTILE DOMAIN-DO NUCLEAR INVAGINATIONS PROVIDE A NANODOMAIN FOR THE MODULATION OF GENE EXPRESSION?
The SR is also contiguous with the outer nuclear envelope (Lesh et al., 1998) and its tubular invaginations (Echevarria et al., 2003; Fricker et al., 1997; Gerasimenko et al., 1995) . However, despite the pivotal role of SR Ca 2+ release in excitation-transcription coupling and thus phenotypic modulation (Cartin et al., 2000; Gomez et al., 2002; Stevenson et al., 2001; Wamhoff et al., 2006) , there have been few detailed investigations on nuclear Ca 2+ signalling in native smooth muscles (Wray and Burdyga, 2010) . The current consensus (Bootman et al., 2009; Queisser et al., 2011) is that the nuclear envelope and its invaginations provide the surface area necessary for direct entry of Ca 2+ into the nucleus via nuclear pores, driven either by Ca 2+ influx across the PM or by activation of RyRs (Marius et al., 2006) and IP 3 Rs (Avedanian et al., 2011; Cardenas et al., 2004; Gerasimenko et al., 1995; Hirose et al., 2008) resident in the deep, perinuclear S/ER. However, early investigations on a variety of cell types including arterial smooth muscle showed that the nuclear membrane restricts direct Ca 2+ flux into the nucleus (Himpens et al., 1992a, b; Neylon et al., 1990; Wamhoff et al., 2006; Waybill et al., 1991; Williams et al., 1985) , raising the possibility that the nuclear membrane independently regulates Ca 2+ signalling. Our pilot studies on pulmonary arterial myocytes not only support this view, but have now provided evidence to suggest that RyR1 and a third subtype of SERCA pump, SERCA1, may be preferentially targeted to the outer nuclear membrane (Evans, 2013; Navarro-Dorado and Evans, 2015) . Although the dimensions of nuclear invaginations vary markedly, their radii rarely exceed 200 nm and many are blind-ended. It is possible, therefore, that nuclear invaginations may incorporate unique pumps and transporters and thus provide nanodomains within which Ca 2+ signals may be segregated, and thus contribute to stimulus-transcription coupling (Wamhoff et al., 2006) .
SUMMARY
We should finish with a summary of the properties conferred by the nanojunctions themselves, and do so in the knowledge that all nanojunctions presently defined create a cytoplasmic nanospace between each junctional membrane pair that is approximately 20 nm across, irrespective of whether we consider the PM-SR junction, L-SR junction, the nuclear invaginations or for that matter the Daddy of them all, the neuromuscular junction. Any curious individual must now recognise the consistency of this argument, so why ~20 nm? This separation of junctional membranes ensures that Ca 2+ transients within the junctional nanospaces are segregated from those in the bulk myoplasm that determines, in the case of arterial smooth muscle, contractile activity. Several factors contribute to the restriction of [Ca 2+ ] transients to nanojunctions: (i) The geometry of the junctions, especially the distance between membranes, appears to control the retention of Ca 2+ in the nanospace, as suggested by preliminary models (Fameli et al., 2007 (Fameli et al., , 2014 ; (ii) The relatively low diffusivity of (free, let alone buffered) cytoplasmic Ca 2+ (Allbritton et al., 1992; Kushmerick and Podolsky, 1969) , in combination with the restricted junctional geometry, favours Ca 2+ buffering by nanojunctions; (iii) The kinetics of Ca 2+ pumps in the junctions is another important element, tightly linked to the previous two factors. For example, if, as predicted, SERCA2b is resident within PM-SR junctions of pulmonary arterial smooth muscle, its high affinity for Ca 2+ (Verboomen et al., 1992) may provide a barrier to Ca 2+ flux between the PM and the myofilaments and vice versa (Clark et al., 2010) ; (iv) Protein complexes that span junctions likely provide physical obstacles to ion mobility in the junctions by increasing path tortuosity (Devine et al., 1972; Poburko et al., 2008) .
As discussed, the defined properties of a given nanojunction may allow pulmonary arterial myocytes and other cell types to coordinate the delivery of Ca 2+ signals in a manner that allows for the selective induction of, for example: (i) vasoconstriction via L-SR junctions; (ii) vasodilation via PM-SR junctions; (iii) gene expression via nuclear invaginations (Figure 8 ). In each case, however, the view proposed is most likely an oversimplification of the Ca 2+ signalling apparatus available to the cell, a point which is articulated by the fact that PM-SR junctions may be polymodal (Boittin et al., 2003; Nazer and Van Breemen, 1998b ; van Breemen et al., 1995) . The precise configuration of junctional complexes may therefore be context dependent, and vary not only between cell types but also throughout the path of cell differentiation, during repair and aging. In short, we are likely at the dawn of a true appreciation of the importance of nanojunctions and the complexity and versatility they afford cellular Ca 2+ signals.
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